Stay updated on CYT-0851 in B-Cell Cancers & Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the CYT-0851 in B-Cell Cancers & Solid Tumors Clinical Trial page.

Latest updates to the CYT-0851 in B-Cell Cancers & Solid Tumors Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page displays the completed CYT-0851 Phase 1/2 trial record, with its study design, eligibility criteria, outcomes, locations, and record dates, rather than a 403 error.SummaryDifference99%

- Check16 days agoChange DetectedThe site footer now identifies the software revision as v3.8.0 instead of v3.7.2. The page still displays a 403 Forbidden error rather than the study record.SummaryDifference0.2%

- Check23 days agoChange DetectedA sitewide notice announces updates to NIH terminology, stating that agencies are using “Super Intelligence” in place of “Artificial Intelligence” during a transition.SummaryDifference1%

- Check30 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.1 to v3.7.2, while the study record continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check37 days agoChange DetectedThe site footer revision changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check57 days agoChange DetectedAccess to the study record now shows a 403 Forbidden error page, replacing the study details with an error screen and standard site navigation. This change represents an access restriction rather than a substantive update to the study content.SummaryDifference23%

Stay in the know with updates to CYT-0851 in B-Cell Cancers & Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CYT-0851 in B-Cell Cancers & Solid Tumors Clinical Trial page.